Copy For Citation
Bakir Ekinci P., Kara E., Er A. G., İnkaya A. Ç., Demirkan K., Uzun Ö.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, vol.88, no.3, pp.1387-1391, 2022 (SCI-Expanded)
-
Publication Type:
Article / Letter
-
Volume:
88
Issue:
3
-
Publication Date:
2022
-
Doi Number:
10.1111/bcp.14953
-
Journal Name:
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
-
Journal Indexes:
Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, BIOSIS, Biotechnology Research Abstracts, CAB Abstracts, EMBASE, International Pharmaceutical Abstracts, MEDLINE, Veterinary Science Database
-
Page Numbers:
pp.1387-1391
-
Lokman Hekim University Affiliated:
No
Abstract
Sir,
There is a cumulative evidence suggesting COVID-19 victims are
prone to COVID-19 associated pulmonary aspergillosis (CAPA).
COVID-19 itself and immunomodulatory medications, such as corticosteroids and tocilizumab, compromise the immune system to an
extent that opportunistic infections complicate the course further. In
this letter, we aimed to highlight the relationship between inflammation and voriconazole trough levels in COVID-19 patients.